Home
About
FAQ
History (0)
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Pardee, Timothy
One or more keywords matched the following items that are connected to
Pardee, Timothy
Item Type
Name
Academic Article
Mouse models of human AML accurately predict chemotherapy response.
Academic Article
Unique dual targeting of thymidylate synthase and topoisomerase1 by FdUMP[10] results in high efficacy against AML and low toxicity.
Academic Article
Overexpression of MN1 confers resistance to chemotherapy, accelerates leukemia onset, and suppresses p53 and Bim induction.
Concept
Antineoplastic Agents
Academic Article
The prognostic importance of polypharmacy in older adults treated for acute myelogenous leukemia (AML).
Academic Article
A phase I study of the first-in-class antimitochondrial metabolism agent, CPI-613, in patients with advanced hematologic malignancies.
Academic Article
The efficacy of the ribonucleotide reductase inhibitor Didox in preclinical models of AML.
Academic Article
Thymineless death in F10-treated AML cells occurs via lipid raft depletion and Fas/FasL co-localization in the plasma membrane with activation of the extrinsic apoptotic pathway.
Academic Article
Improving nucleoside analogs via lipid conjugation: Is fatter any better?
Academic Article
The applications of the novel polymeric fluoropyrimidine F10 in cancer treatment: current evidence.
Academic Article
A Phase II Clinical Trial of CPI-613 in Patients with Relapsed or Refractory Small Cell Lung Carcinoma.
Academic Article
The novel phospholipid mimetic KPC34 is highly active against preclinical models of Philadelphia chromosome positive acute lymphoblastic leukemia.
Academic Article
Mitochondria in cancer metabolism, an organelle whose time has come?
Academic Article
Systematic Dissection of the Metabolic-Apoptotic Interface in AML Reveals Heme Biosynthesis to Be a Regulator of Drug Sensitivity.
Search Criteria
Antineoplastic Agents